1. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Issue 10108 (11th November 2017) Authors: Huh, Warner K; Joura, Elmar A; Giuliano, Anna R; Iversen, Ole-Erik; de Andrade, Rosires Pereira; Ault, Kevin A; Bartholomew, Deborah; Cestero, Ramon M; Fedrizzi, Edison N; Hirschberg, Angelica L; Mayrand, Marie-Hélène; Ruiz-Sternberg, Angela Maria; Stapleton, Jack T; Wiley, Dorothy J; Ferenczy, A... Journal: Lancet Issue: Volume 390:Issue 10108(2017) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗